Search

Author/Creator Soret, J.

1. 205 A SINGLE CENTER REPORT OF THERAPEUTIC STRATEGIES IN PATIENTS WITH ATYPICAL CML (ACML) AND UNCLASSIFIED MDS/MPN (MDS/MPN-U). Issue 1 (April 2015)

Authors:
Braun, T.; Debache, A.; Roudot, H.; Lusina, D.; Thépot, S.; Eclache, V.; Martin, A.; Soret, J.; Bréchignac, S.; Kelaidi, C.; Adès, L.; Fenaux, P.; Gardin, C.
Journal:
Leukemia research
Issue:
Volume 39:Issue 1(2015:Jan.)
Page Start:
S102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A. (August 2018)

Authors:
Kelaidi, C.; Braun, T.; Arana, R.; Marceau-Renaut, A.; Lazarian, G.; Soret, J.; Cereja, S.; Letestu, R.; Eclache, V.; Lusina, D.; Baran-Marszak, F.; Ades, L.; Preudhomme, C.; Martin, A.; Fenaux, P.; Gardin, C.
Journal:
Leukemia research
Issue:
Volume 71(2018)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION. (23rd June 2022)

Authors:
Röth, A.; Egyed, M.; Ichikawa, S.; Ito, Y.; Kim, J. S.; Nagy, Z.; Obara, N.; Panse, J.; Schrezenmeier, H.; Sica, S.; Soret, J.; Usuki, K.; Yoon, S.-S.; Benkali, K.; Buri, M.; Lundberg, P.; Patel, H.; Shinomiya, K.; Sreckovic, S.; Nishimura, J.-I.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗